Literature DB >> 10722257

Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study.

K P White1, M Speechley, M Harth, T Ostbye.   

Abstract

OBJECTIVE: To determine the proportion of adults with fibromyalgia syndrome (FMS) in the general population who also meet the 1988 Centre for Disease Control (CDC) criteria for chronic fatigue syndrome (CFS).
METHODS: Seventy-four FMS cases were compared with 32 non-FMS controls with widespread pain and 23 with localized pain, all recruited in a general population survey.
RESULTS: Among females, 58.0% of fibromyalgia cases met the full criteria for CFS, compared to 26.1% and 12.5% of controls with widespread and localized pain, respectively (p=0.0006). Male percentages were 80.0, 22.2, and zero, respectively (p=0.003). Compared to those with FMS alone, those meeting the case definitions for both FMS and CFS reported a worse course, worse overall health, more dissatisfaction with health, more non-CFS symptoms, and greater disease impact. The number of total symptoms and non-CFS symptoms were the best predictors of co-morbid CFS.
CONCLUSIONS: There is significant clinical overlap between CFS and FMS.

Entities:  

Mesh:

Year:  2000        PMID: 10722257     DOI: 10.1080/030097400750001798

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  24 in total

1.  Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement.

Authors:  O Zachrisson; P Colque-Navarro; C G Gottfries; B Regland; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-20       Impact factor: 3.267

2.  The development and psychometric validation of the central sensitization inventory.

Authors:  Tom G Mayer; Randy Neblett; Howard Cohen; Krista J Howard; Yun H Choi; Mark J Williams; Yoheli Perez; Robert J Gatchel
Journal:  Pain Pract       Date:  2011-09-27       Impact factor: 3.183

Review 3.  Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide.

Authors:  Salih Ozgocmen; Huseyin Ozyurt; Sadik Sogut; Omer Akyol
Journal:  Rheumatol Int       Date:  2005-11-20       Impact factor: 2.631

4.  Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study.

Authors:  Omer Faruk Sendur; Yasemin Turan; Engin Tastaban; Cigdem Yenisey; Mukadder Serter
Journal:  Rheumatol Int       Date:  2008-10-14       Impact factor: 2.631

5.  Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

6.  Depression, attribution style and self-esteem in chronic fatigue syndrome and fibromyalgia patients: is there a link?

Authors:  H J Michielsen; B Van Houdenhove; I Leirs; A Vandenbroeck; P Onghena
Journal:  Clin Rheumatol       Date:  2005-07-12       Impact factor: 2.980

7.  Prevalence, overlap, and predictors of functional somatic syndromes in a student sample.

Authors:  Susanne Fischer; Jens Gaab; Ulrike Ehlert; Urs M Nater
Journal:  Int J Behav Med       Date:  2013-06

8.  Prescribed exercise in people with fibromyalgia: parallel group randomised controlled trial.

Authors:  Selwyn C M Richards; David L Scott
Journal:  BMJ       Date:  2002-07-27

9.  Gene expression profiles of fatigued fibromyalgia patients with different categories of pain and catastrophizing: a preliminary report.

Authors:  Nada Lukkahatai; Benjamin Majors; Swarnalatha Reddy; Brian Walitt; Leorey N Saligan
Journal:  Nurs Outlook       Date:  2013-05-16       Impact factor: 3.250

Review 10.  Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes.

Authors:  Gerhard K M Endresen
Journal:  Rheumatol Int       Date:  2003-07-16       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.